跳至主要内容
临床试验/NCT03874949
NCT03874949已完成不适用

Comparison of Postoperative Pain After Root Canal Obturation With Sealer Containing or Not 1% Enoxolone: a Randomized Clinical Trial

ACTEON Group2 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2019年4月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
95
试验地点
2
主要终点
Postoperative pain

研究概览

简要总结

This study aims to assess the efficacy of a zinc oxide eugenol sealer containing Enoxolone, a non-steroidal anti inflammatory drug (NSAID) on the pain relief after endodontic treatment.

The study design is a multicenter, doubled blinded randomized controlled trial. The comparator is the equivalent zinc oxide eugenol sealer without NSAID (allocation ratio is 1:1). The conventional endodontic treatment, using gutta percha and sealer, is done. Patients assess their pain for 7 days after permanent root obturation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male or female aged from 18 to 70 years,
  • patient requiring root canal treatment on permanent mature teeth (single rooted teeth, premolar or molar),
  • Informed consent signed,
  • Patient with social protection.

排除标准

  • root canal retreatment,
  • root canal treatment on an immature tooth,
  • calcified root canal assessed radiographically,
  • Patient with one or more documented contraindication to endodontic treatment,
  • Patient who takes regular analgesic or anti-inflammatory therapy for another pathology,
  • Known allergy to NSAID or to one component of the sealer formula,
  • Participation to another clinical trial at the same time,
  • known pregnancy or lactation,
  • Patients with legal protection.

结局指标

主要结局

Postoperative pain

时间窗: 24 hours

To assess the efficacy of Enoxolone contained in the SEALITE Ultra formula compared to the SEALITE Regular formula, the pain is assessed by patients on a diary using a Visual Analogue Scale (VAS : 0-100 mm) 24 hours after the root canal obturation.

次要结局

  • Adverse events(7 days)
  • Use of oral pain treatment(7 days)
  • Pain response profil(0 hour, 6 hours, 12 hours, 24 hours, Day 2, Day 3, Day 7)

研究者

发起方
ACTEON Group
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验